Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biyu Yang

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Iscience|March 12, 2026
Pharmaco-genomic characterization of pancreatic and biliary tract cancer tumoroids for drug responseKun Fang, Wenxin Zhang, Qing Zhao, et al.
Molecular Cancer Therapeutics|July 31, 2024
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune ActivationHangtian Yue, Hui Xu, Lanping Ma, et al.
Journal of Medicinal Chemistry|February 7, 2025
Development of ASGR-Mediated Hepatocyte-Targeting Cytotoxic Drug Conjugates with CTSB-Cleavable Linkers Incorporating Succinimide and Succinic Acid MonoamideJingsheng Jiang, Sigang Jian, Feifei Lin, et al.
European Journal of Medicinal Chemistry|May 5, 2026
Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673Xilin Lyu, Zhiyi Wang, Yanyan Shen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2026
Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron TomographyYunwen Qian, Yalan Wan, Chen Chen, et al.
Journal of Medicinal Chemistry|January 30, 2026
Marine-Derived Bromotyrosine Alkaloids as Potent hCYP1B1 Inhibitors to Overcome Paclitaxel ResistanceQuan Xu, Yuan Xiong, Yanfen Fang, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting ParthanatosChao Chen, Kaiyuan Liu, Xinlei Wang, et al.
Signal Transduction and Targeted Therapy|April 11, 2023
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitorsXu Zhang, Yuxiang Wang, Xi Zhang, et al.
Nature Communications|February 3, 2026
Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer's disease-like pathology in miceYawen Li, Hui Wang, Dongyuan Zhang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Iscience|March 12, 2026
Pharmaco-genomic characterization of pancreatic and biliary tract cancer tumoroids for drug responseKun Fang, Wenxin Zhang, Qing Zhao, et al.
Molecular Cancer Therapeutics|July 31, 2024
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune ActivationHangtian Yue, Hui Xu, Lanping Ma, et al.
Journal of Medicinal Chemistry|February 7, 2025
Development of ASGR-Mediated Hepatocyte-Targeting Cytotoxic Drug Conjugates with CTSB-Cleavable Linkers Incorporating Succinimide and Succinic Acid MonoamideJingsheng Jiang, Sigang Jian, Feifei Lin, et al.
European Journal of Medicinal Chemistry|May 5, 2026
Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673Xilin Lyu, Zhiyi Wang, Yanyan Shen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2026
Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron TomographyYunwen Qian, Yalan Wan, Chen Chen, et al.
Journal of Medicinal Chemistry|January 30, 2026
Marine-Derived Bromotyrosine Alkaloids as Potent hCYP1B1 Inhibitors to Overcome Paclitaxel ResistanceQuan Xu, Yuan Xiong, Yanfen Fang, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting ParthanatosChao Chen, Kaiyuan Liu, Xinlei Wang, et al.
Signal Transduction and Targeted Therapy|April 11, 2023
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitorsXu Zhang, Yuxiang Wang, Xi Zhang, et al.
Nature Communications|February 3, 2026
Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer's disease-like pathology in miceYawen Li, Hui Wang, Dongyuan Zhang, et al.
Pageof 2